1963 related articles for article (PubMed ID: 16808908)
1. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
2. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
3. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
Habib HM; Taher TE; Isenberg DA; Mageed RA
Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
[TBL] [Abstract][Full Text] [Related]
4. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
5. [Role of Fas-FasL and caspase-3 signal transduction pathway in promoting apoptosis of T lymphocyte subset in SLE patients].
Chen X; Wang LL; Cai B; Chen J; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):588-90. PubMed ID: 16948902
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
[TBL] [Abstract][Full Text] [Related]
7. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
8. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
9. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
[TBL] [Abstract][Full Text] [Related]
11. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
[TBL] [Abstract][Full Text] [Related]
12. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
[TBL] [Abstract][Full Text] [Related]
13. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
Feng Y
Hokkaido Igaku Zasshi; 1997 Jul; 72(4):443-55. PubMed ID: 9266252
[TBL] [Abstract][Full Text] [Related]
14. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
[TBL] [Abstract][Full Text] [Related]
15. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
Li B; Bassiri H; Rossman MD; Kramer P; Eyuboglu AF; Torres M; Sada E; Imir T; Carding SR
J Immunol; 1998 Aug; 161(3):1558-67. PubMed ID: 9686624
[TBL] [Abstract][Full Text] [Related]
17. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
[TBL] [Abstract][Full Text] [Related]
18. [Study of fas-mediated Foxp3+CD4+CD25+ Treg cell apoptosis in patients with systemic lupus erythematosus].
Lin XJ; Luo M; Cai XY
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(9):586-90. PubMed ID: 21600126
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
20. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
